ArticleMolecular oncology2018

Preclinical evidence of the enhanced effectiveness of combined rapamycin and AICAR in reducing kidney cancer.

Sitai Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.